A rabdomized, double blind, placebo controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib after completion of chemotherapy with bevacizumab for the first line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer
Grant Data
Project Title
A rabdomized, double blind, placebo controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib after completion of chemotherapy with bevacizumab for the first line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer
Principal Investigator
Professor Ho, James Chung Man
(Principal Investigator (PI))
Co-Investigator(s)
Dr Lam David Chi Leung
(Co-Investigator)
Dr Wong Matthew King Yan
(Co-Investigator)
Dr Wang Julie Kwan Ling
(Co-Investigator)
Duration
25
Start Date
2007-08-21
Completion Date
2009-08-31
Amount
288359
Conference Title
A rabdomized, double blind, placebo controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib after completion of chemotherapy with bevacizumab for the first line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer
Keywords
locally advanced NSCLC, metastatic NSCLC, recurrent NSCLC
Discipline
RespirationCancer
HKU Project Code
N/A
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2007
Status
Completed